|
|
|
|
||
from CHM 760 on biotech board - Bakers sell chunkThe Bakers last expressed displeasure when BLCM had fallen 6-9 months behind on clinical trial commitment. "Re: Interesting observation - BLCMIt should also be noted that BB still owns 4,151,578 shares of BLCM... but dispositions help to explain the stock price this week. " |
return to message board, top of board |